Evaluation of the Single-item Self-rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2012 Oct 31

PMID 23108721

Citations 107

Authors

B J Feldman

R J Fredericksen

P K Crane

S A Safren

M J Mugavero

James H Willig

J M Simoni

I B Wilson

M S Saag

M M Kitahata

H M Crane

Affiliations

Soon will be listed here.

Abstract

The self-rating scale item (SRSI) is a single-item self-report adherence measure that uses adjectives in a 5-point Likert scale, from "very poor" to "excellent," to describe medication adherence over the past 4 weeks. This study investigated the SRSI in 2,399 HIV-infected patients in routine care at two outpatient primary HIV clinics. Correlations between the SRSI and four commonly used adherence items ranged from 0.37 to 0.64. Correlations of adherence barriers, such as depression and substance use, were comparable across all adherence items. General estimating equations suggested the SRSI is as good as or better than other adherence items (p's <0.001 vs. <0.001-0.99) at predicting adherence-related clinical outcomes, such as HIV viral load and CD4(+) cell count. These results and the SRSI's low patient burden suggest its routine use could be helpful for assessing adherence in clinical care and should be more widespread, particularly where more complex instruments may be impractical.

Citing Articles

Alcohol use and HIV suppression after completion of financial incentives for alcohol abstinence and isoniazid adherence: a randomized controlled trial.

Muyindike W, Fatch R, Lodi S, Emenyonu N, Kekibiina A, Adong J EClinicalMedicine. 2025; 80:103045.

PMID: 39867970 PMC: 11764067. DOI: 10.1016/j.eclinm.2024.103045.

Assessing the Impact of Social Determinants of Health on HIV Care Engagement in the Southern United States: A Cross-Sectional Study.

Sohail M, Cleveland J, McCollum C, Burgan K, Hearld L, Carodine A J Int Assoc Provid AIDS Care. 2024; 23:23259582241251728.

PMID: 38816001 PMC: 11301729. DOI: 10.1177/23259582241251728.

Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.

Tumwegamire A, Fatch R, Emenyonu N, Lodi S, Muyindike W, Kekibiina A PLoS One. 2024; 19(3):e0300508.

PMID: 38507431 PMC: 10954112. DOI: 10.1371/journal.pone.0300508.

HealthCall: Smartphone Enhancement of Brief Interventions to Improve HIV Medication Adherence Among Patients in HIV Care.

Knox J, Aharonovich E, Zingman B, Stohl M, Walsh C, Elliott J AIDS Behav. 2024; 28(6):1912-1922.

PMID: 38478322 PMC: 11793903. DOI: 10.1007/s10461-024-04289-z.

A randomized controlled trial of the dissemination of an mHealth intervention for improving health outcomes: the WiseApp for Spanish-speakers living with HIV study protocol.

Olaya F, Brin M, Caraballo P, Halpern M, Jia H, Ramirez S BMC Public Health. 2024; 24(1):201.

PMID: 38233908 PMC: 10792787. DOI: 10.1186/s12889-023-17538-y.

References

Berg K, Wilson I, Li X, Arnsten J . Comparison of antiretroviral adherence questions. AIDS Behav. 2010; 16(2):461-8. PMC: 3690952. DOI: 10.1007/s10461-010-9864-z. View

Spitzer R, Kroenke K, Williams J . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18):1737-44. DOI: 10.1001/jama.282.18.1737. View

Bangsberg D, Hecht F, Clague H, Charlebois E, Ciccarone D, Chesney M . Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 26(5):435-42. DOI: 10.1097/00126334-200104150-00005. View

Glass T, de Geest S, Hirschel B, Battegay M, Furrer H, Covassini M . Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther. 2008; 13(1):77-85. View

Amico K, Fisher W, Cornman D, Shuper P, Redding C, Konkle-Parker D . Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006; 42(4):455-9. DOI: 10.1097/01.qai.0000225020.73760.c2. View

Gifford A, Bormann J, Shively M, WRIGHT B, Richman D, Bozzette S . Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000; 23(5):386-95. DOI: 10.1097/00126334-200004150-00005. View

Eldred L, Wu A, Chaisson R, Moore R . Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(2):117-25. DOI: 10.1097/00042560-199806010-00003. View

Bradley K, Bush K, Epler A, Dobie D, Davis T, Sporleder J . Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003; 163(7):821-9. DOI: 10.1001/archinte.163.7.821. View

Simoni J, Kurth A, Pearson C, Pantalone D, Merrill J, Frick P . Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006; 10(3):227-45. PMC: 4083461. DOI: 10.1007/s10461-006-9078-6. View

10.

Kitahata M, Rodriguez B, Haubrich R, Boswell S, Mathews W, Lederman M . Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol. 2008; 37(5):948-55. PMC: 2597168. DOI: 10.1093/ije/dym231. View

11.

Ingersoll K . The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care. 2003; 16(2):199-211. DOI: 10.1080/09540120410001641048. View

12.

Fletcher C, Testa M, Brundage R, Chesney M, Haubrich R, Acosta E . Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. J Acquir Immune Defic Syndr. 2005; 40(3):301-6. DOI: 10.1097/01.qai.0000180078.53321.6a. View

13.

Wood E, Hogg R, Yip B, Harrigan P, OShaughnessy M, Montaner J . Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. AIDS. 2003; 17(5):711-20. DOI: 10.1097/00002030-200303280-00009. View

14.

STEPHENSON B, Rowe B, Haynes R, Macharia W, Leon G . The rational clinical examination. Is this patient taking the treatment as prescribed?. JAMA. 1993; 269(21):2779-81. View

15.

Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K . The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998; 158(16):1789-95. DOI: 10.1001/archinte.158.16.1789. View

16.

Gual A, Segura L, Contel M, Heather N, Colom J . Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002; 37(6):591-6. DOI: 10.1093/alcalc/37.6.591. View

17.

Newcombe D, Humeniuk R, Ali R . Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005; 24(3):217-26. DOI: 10.1080/09595230500170266. View

18.

Hogg R, Heath K, Bangsberg D, Yip B, Press N, OShaughnessy M . Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002; 16(7):1051-8. DOI: 10.1097/00002030-200205030-00012. View

19.

Wagner G, Kanouse D, Golinelli D, Miller L, Daar E, Witt M . Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006; 20(9):1295-302. DOI: 10.1097/01.aids.0000232238.28415.d2. View

20.

Gross R, Bilker W, Friedman H, Coyne J, Strom B . Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS. 2002; 16(13):1835-7. DOI: 10.1097/00002030-200209060-00021. View